Evidence map›Paper›PMID 27776514›Full record

ArticleInternational journal of health geographics2016

Optimal health and disease management using spatial uncertainty: a geographic characterization of emergent artemisinin-resistant Plasmodium falciparum distributions in Southeast Asia.

Eric P M Grist, Jennifer A Flegg, Georgina Humphreys, Ignacio Suay Mas, Tim J C Anderson, Elizabeth A Ashley, Nicholas P J Day, Mehul Dhorda, Arjen M Dondorp, M Abul Faiz and 24 more

Open access · goldAbstract read
In one paragraph

Article in International journal of health geographics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. A spatio-temporal model of multi-marker antimalarial resistance.Journal of the Royal Society, Interface · 2024
    Article
  6. Article
  7. Mapping partner drug resistance to guide antimalarial combination therapy policies in sub-Saharan Africa.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  8. On the emergence, spread and resistance ofJournal of medical microbiology · 2021
    Review
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 14 institutions in 11 countries.

Eric P M GristWorldWide Antimalarial Resistance Network (WWARN), Oxford, UK. epmgrist@gmail.com.
Jennifer A FleggWorldWide Antimalarial Resistance Network (WWARN), Oxford, UK.
Georgina HumphreysWorldWide Antimalarial Resistance Network (WWARN), Oxford, UK.
Ignacio Suay MasWorldWide Antimalarial Resistance Network (WWARN), Oxford, UK.
Tim J C AndersonDepartment of Genetics, Texas Biomedical Research Institute, San Antonio, TX, USA.
Elizabeth A AshleyNuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, OX3 7LJ, UK.
Nicholas P J DayMahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand.
Mehul DhordaWorldWide Antimalarial Resistance Network (WWARN), Oxford, UK.
Arjen M DondorpNuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, OX3 7LJ, UK.
M Abul FaizMahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand.
Peter W GethingSpatial Epidemiology and Ecology Group, Department of Zoology, University of Oxford, Oxford, UK.
Tran T HienNuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, OX3 7LJ, UK.
Tin M HlaingDefence Services Medical Research Centre, Naypyitaw, Myanmar.
Mallika ImwongDepartment of Molecular Tropical Medicine and Genetics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Jean-Marie KindermansMédecins Sans Frontières, Brussels, Belgium.
Richard J MaudeNuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, OX3 7LJ, UK.
Mayfong MayxayNuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, OX3 7LJ, UK.
Marina McDew-WhiteDepartment of Genetics, Texas Biomedical Research Institute, San Antonio, TX, USA.
Didier MenardMalaria Molecular Epidemiology Unit, Institute Pasteur in Cambodia, Phnom Penh, Cambodia.
Shalini NairDepartment of Genetics, Texas Biomedical Research Institute, San Antonio, TX, USA.
Francois NostenNuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, OX3 7LJ, UK.
Paul N NewtonWorldWide Antimalarial Resistance Network (WWARN), Oxford, UK.
Ric N PriceWorldWide Antimalarial Resistance Network (WWARN), Oxford, UK.
Sasithon PukrittayakameeFaculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Shannon Takala-HarrisonInstitute for Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
Frank SmithuisNuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, OX3 7LJ, UK.
Nhien T NguyenHospital for Tropical Disease, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Kyaw M TunDefence Services Medical Research Centre, Naypyitaw, Myanmar.
Nicholas J WhiteNuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, OX3 7LJ, UK.
Benoit WitkowskiWorldWide Antimalarial Resistance Network (WWARN), Oxford, UK.
Charles J WoodrowNuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, OX3 7LJ, UK.
Rick M FairhurstLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.
Carol Hopkins SibleyWorldWide Antimalarial Resistance Network (WWARN), Oxford, UK.
Philippe J GuerinWorldWide Antimalarial Resistance Network (WWARN), Oxford, UK.
Angkor Hospital for Children · KHMahidol Oxford Tropical Medicine Research Unit · THWorldwide Veterinary Service · GBMyanmar Oxford Clinical Research Unit · MMTexas Biomedical Research Institute · USLao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit · LAOxford University Clinical Research Unit · VNInstitut Pasteur du Cambodge · KHMahidol University · THMédecins Sans Frontières · BEMenzies School of Health Research · AUUniversity of Maryland, Baltimore · USUniversity of Oxford · GBVector Oncology (United States) · US

Funding

Malaria Pathogenesis and Human ImmunityZIAAI001000 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI FAIRHURST, RICK · 2009 to 2017
$9.3M
Mapping Drug Resistance Genes in Plasmodium falciparumR37AI048071 · NIAID · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI ANDERSON, TIM J · 2012 to 2021
$7.9M
EXTRAMULAR RESEARCH FACILITIES CONSTRUCTIONC06RR017515 · NCRR · SOUTHWEST FOUNDATION FOR BIOMEDICAL RES · PI SHADE, ROBERT E · 2003 to 2003
$3.1M
Genome-wide studies to identify markers of artemisinin-resistant malariaR01AI101713 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI HARRISON, SHANNON TAKALA · 2013 to 2016
$1.8M
MOLECULAR AND BIOCHEMICAL GENETICS LABORATORY RENOVATIONC06RR013556 · NCRR · SOUTHWEST FOUNDATION FOR BIOMEDICAL RES · PI SHADE, ROBERT E · 1998 to 1998
–
NCRR NIH HHS C06 RR013556NCRR NIH HHS C06 RR017515NIAID NIH HHS R01 AI101713NIAID NIH HHS R37 AI048071Wellcome Trust 200909/Z/16/Z
6 · The paper itself

Abstract

backgroundArtemisinin-resistant Plasmodium falciparum malaria parasites are now present across much of mainland Southeast Asia, where ongoing surveys are measuring and mapping their spatial distribution. These efforts require substantial resources. Here we propose a generic 'smart surveillance' methodology to identify optimal candidate sites for future sampling and thus map the distribution of artemisinin resistance most efficiently.

methodsThe approach uses the 'uncertainty' map generated iteratively by a geostatistical model to determine optimal locations for subsequent sampling.

resultsThe methodology is illustrated using recent data on the prevalence of the K13-propeller polymorphism (a genetic marker of artemisinin resistance) in the Greater Mekong Subregion.

conclusionThis methodology, which has broader application to geostatistical mapping in general, could improve the quality and efficiency of drug resistance mapping and thereby guide practical operations to eliminate malaria in affected areas.

Indexed as

Communicable Diseases, EmergingDisease ManagementDrug ResistanceGeographyHealth StatusAnti-Infective AgentsArtemisininsAsia, SoutheasternHumansMalaria, FalciparumPlasmodium falciparumPopulation SurveillanceAnti-Infective AgentsartemisininArtemisininsArtemisininDrug resistanceGreater Mekong SubregionMalariaSurveillance

Identifiers

PMID27776514
PMCPMC5078981
OpenAlexW2536276826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.